{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:27:52Z","timestamp":1747178872220,"version":"3.40.5"},"reference-count":94,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Emerging Drugs"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1080\/14728214.2020.1822816","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T17:24:31Z","timestamp":1599758671000},"page":"433-444","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Emerging drugs for the treatment of Waldenstr\u00f6m macroglobulinemia"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0618-8900","authenticated-orcid":false,"given":"Fotiou","family":"Despina","sequence":"first","affiliation":[{"name":"Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8990-3254","authenticated-orcid":false,"given":"Dimopoulos","family":"Meletios Athanasios","sequence":"additional","affiliation":[{"name":"Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8191-5832","authenticated-orcid":false,"given":"Kastritis","family":"Efstathios","sequence":"additional","affiliation":[{"name":"Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50082"},{"key":"cit0002","doi-asserted-by":"crossref","unstructured":"Teras LR, DeSantis CE, Cerhan JR, et al. US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016 Sept 12;66(6):443\u2013459","DOI":"10.3322\/caac.21357"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50063"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj111"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-384768"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15201"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-172080"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50038"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-711234"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00394"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-174961"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0431-y"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.070458"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0007"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200710"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-457101"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24955"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25802"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0197-7"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1506192"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-525808"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2019.1649132"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16088"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-550905"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13897"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.026"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30087-5"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.09.039"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20658"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-647420"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"issue":"1","key":"cit0032","first-page":"146","volume":"186","author":"Laribi K","year":"2018","journal-title":"A study on behalf of the French Innovative Leukaemia Organization (FILO). Br J Haematol"},{"key":"cit0033","first-page":"1","volume":"14","author":"Tedeschi A","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2011.n.030"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-177329"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26303"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24405"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1233541"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-503862"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21788"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.3237"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-742411"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.4677"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501548"},{"key":"cit0045","first-page":"2776","volume":"130","author":"Treon S","year":"2017","journal-title":"Blood"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-111178"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802917"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30632-5"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.186908"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.191999"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.156"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.171041"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.164103"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400029"},{"issue":"12","key":"cit0055","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.4049\/jimmunol.153.12.5607","volume":"153","author":"Sideras P","year":"1994","journal-title":"J Immunol"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-338855"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2000.imr017504.x"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830231210"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.11.012"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1038\/sj.icb.7100095"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-115170"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1038\/nature09121"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-475111"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-811752"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0277-6"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761726"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0313-y"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_58"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0163"},{"key":"cit0070","unstructured":"BeiGene Announces Results of Phase 3 ASPEN Trial of Zanubrutinib Compared to Ibrutinib for the Treatment of Patients with Waldenstr\u00f6m\u2019s Macroglobulinemia [Internet]. Press release; 2019; Dec 16. Available from: http:\/\/ir.beigene.com\/news-releases\/news-release-details\/beigene-announces-results-phase-3-aspen-trial-zanubrutinib\/"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.242909"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7501"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30210-8"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-126286"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.2032.2032"},{"key":"cit0076","unstructured":"Ward R, Arnold D, et al. A phase 1a study to investigate the safety, pharmacokinetics, and pharmacodynamics of the non covalent Bruton\u2019s Tyrosine Kinase inhibitor SNS-062 in healthy subjects: preliminary results. Presented at the 2nd International Conference on New Concepts in B-Cell Malignancies; San Diego, CA; 2016."},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-124614"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-564583"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-130636"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1462"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0152"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-566273"},{"key":"cit0083","first-page":"503","volume":"124","author":"Meid K","year":"2017","journal-title":"Blood"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50045"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-112325"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.4255.4255"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3290"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1222380"},{"key":"cit0089","doi-asserted-by":"crossref","unstructured":"Tomowiak C, editor Open label non-randomized phase II study exploring \u201cchemo-free\u201d treatment association with idelalisib+ obinutuzumab in patients with relpased\/refractory (R\/R) Waldenstrom\u2019s macroglobulinemia. Orlando: ASH;2019","DOI":"10.1182\/blood-2019-122826"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1918"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.164"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-150854"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0862"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24175"}],"container-title":["Expert Opinion on Emerging Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728214.2020.1822816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T04:55:54Z","timestamp":1696654554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728214.2020.1822816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10,1]]}},"alternative-id":["10.1080\/14728214.2020.1822816"],"URL":"https:\/\/doi.org\/10.1080\/14728214.2020.1822816","relation":{},"ISSN":["1472-8214","1744-7623"],"issn-type":[{"type":"print","value":"1472-8214"},{"type":"electronic","value":"1744-7623"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}